Since the emergence of molecular genetics more than fifty years ago, scientists have tried to isolate haploid mammalian cells, that is, cells with half the number of chromosomes contained in somatic cells.
Haploid cells are a powerful genetic tool to analyse gene function. In the past decade, a number of researchers finally succeeded in developing haploid cell line cultures. However, these cell lines are unstable and have a tendency for diploidisation. Now, researchers have identified chemical compounds that increase the stability of mammalian haploid cell lines. The study is published in the journal Cell Reports.
With the exception of sperm and egg cells, human cells have two sets of chromosomes, one inherited from each parent. Organisms with only one set of chromosomes, however, can be extremely useful for scientific research. "Cells with a single set of chromosomes are a powerful tool to study gene functions, because you can modify just one copy of the gene to analyse its effects on the organism," says the leader of the study.
Haploid cells in microorganisms such as yeasts have been extensively used for gaining powerful insights that have revolutionised the history of biomedicine. Yeasts were used, for instance, by the 2001 Nobel Laureates in Physiology to identify key molecules that regulate the cell cycle in eukaryotic organisms. However, yeasts and humans are separated by a billion years of evolution, and many biological mechanisms have not been retained, which means they cannot be studied in these microorganisms.
Since mammalian haploid cell cultures were not available until recently, researchers have used other tools to conduct genetic screens, such as interfering RNA. However, these alternative strategies have non-specific effects that are inconvenient for any genetic approach. Over the past years, scientists have managed to isolate mammalian haploid cell lines. First, a near-haploid cell line was obtained from a leukaemia patient; years later, methods were developed to establish embryonic haploid stem cell lines from a number of mammals, including humans. However, all these animal haploid cell cultures are highly unstable and become diploid quickly.
"Two years ago, we found that haploid cells activate mechanisms of cell death via the p53 protein; as a result, haploid cells are no longer viable in culture and progressively disappear," says the lead. "These results explained why it is so difficult to maintain animal haploid cells in the lab."
Now, the researchers have used chemical screening methods to search among nearly 1,000 compounds for those that select haploid cells against cells with a larger number of chromosomes. The study revealed that a precursor in the synthesis of the anticancer agent Taxol named DAB (10-Deacetylbacattin III) allows haploid cells to grow better and replace diploid cells in cultures.
"This compound acts on microtubules, factors involved in the migration of chromosomes during cell division. When microtubules are challenged using DAB, cells with a larger number of chromosomes are more seriously affected, while cells with a lower number of chromosomes are able to continue with cell division." This effect is not limited to haploid cells, since tetraploid cells (cells with four sets of chromosomes) exposed to DAB are also more significantly affected than diploid cells. In other words, this strategy allows researchers to generically select for cells with a lower number of chromosomes in mixed cultures of mammalian cells.
Regardless of the usefulness of these results for researchers working with animal haploid cells, the study is also of relevance for cancer researchers, as the effects of DAB can also be obtained with small doses of the anti-cancer drug Taxol. In this context, the authors want to propose that low doses of taxanes might allow for the selective elimination of polyploid cells, which recent genomic studies indicate might be present in up to 37 per cent of human tumors. Thus, "the results of this study might help identify cancer patients that might preferentially benefit from a treatment using taxol or other taxane derivatives," says the author.
https://www.cnio.es/en/news/cnio-researchers-find-a-method-to-select-for-mammalian-cells-with-half-the-number-of-chromosomes/
https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30833-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-chemical-screen&filter=22
Selecting mammalian cells with half the number of chromosomes
- 854 views
- Added
Edited
Latest News
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Full-length mRNA packaged i…
By newseditor
Posted 22 Apr
Glucose-sensing mechanism t…
By newseditor
Posted 21 Apr
Other Top Stories
Immunotherapy against clotting factor to protect neuroinflammation…
Read more
How gene activity shapes immunity across species
Read more
Glutamine metabolism affects T cell signaling and function
Read more
Nature of immune cells in the human brain disclosed
Read more
Immune cells could hold key to therapies for spinal cord injuries
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Neuronal activity rapidly r…
By newseditor
Posted 22 Apr
A perspective on muscle phe…
By newseditor
Posted 22 Apr
Foxp1 suppresses cortical a…
By newseditor
Posted 22 Apr
Single-cell long-read seque…
By newseditor
Posted 22 Apr
Unlocking potential: the ro…
By newseditor
Posted 22 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar